← Back to directory
Not currently recruitingFunding unknown
- Works count
- 1,484
- Citation count
- 72,978
- H-index
- 116
- i10-index
- 519
Research interests
Medicine
Biochemistry, Genetics and Molecular Biology
Advanced Breast Cancer Therapies
HER2/EGFR in Cancer Research
Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies
Cancer Immunotherapy and Biomarkers
Publications
Pembrolizumab for Early Triple-Negative Breast Cancer
New England Journal of Medicine · 2020 · https://doi.org/10.1056/nejmoa1910549
Breast cancer
Nature Reviews Disease Primers · 2019 · https://doi.org/10.1038/s41572-019-0111-2
Trastuzumab Deruxtecan in Previously Treated HER2-Positive Breast Cancer
New England Journal of Medicine · 2019 · https://doi.org/10.1056/nejmoa1914510
Pertuzumab, Trastuzumab, and Docetaxel in HER2-Positive Metastatic Breast Cancer
New England Journal of Medicine · 2015 · https://doi.org/10.1056/nejmoa1413513
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
New England Journal of Medicine · 2011 · https://doi.org/10.1056/nejmoa1113216
Current projects
No projects listed.